| Tue, Dec 15, 2009 | | | Data Safety Monitoring Board (DSMB) Approves Advancement to Intermediate Dose Level of PLX-PAD Business Wire (Tue, Dec 15)
| | Tue, Dec 1, 2009 | | | Pluristem Therapeutics Completes Dosing of First Group of Patients in Europe With Placenta-Derived Cell Therapy Product PLX-PAD in Phase I Clinical Trial for Treatment of Critical Limb Ischemia (CLI) GlobeNewswire (Tue, Dec 1)
| | Thu, Nov 19, 2009 | | | Pluristem Therapeutics Presents Three Month Follow-Up Data from First Patient to Receive Placental Derived PLX-PAD at Two Meetings in Germany and France Business Wire (Thu, Nov 19)
| | Tue, Nov 17, 2009 | | | PLURISTEM THERAPEUTICS INC Financials EDGAR Online Financials (Tue, Nov 17)
| | | Pluristem Therapeutics Announces Three Month Follow-Up Data from the First Patient to Receive PLX-PAD Business Wire (Tue, Nov 17)
| | Thu, Nov 12, 2009 | | | PLURISTEM THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report EDGAR Online (Thu, Nov 12)
| | Wed, Nov 11, 2009 | | | Can Stem Cells Put an End To Paralysis? Indie Research (Wed, Nov 11)
| | Tue, Oct 20, 2009 | | | Pluristem Therapeutics Will Chair a Panel Presentation on Placenta-Derived Adult Stem Cells at the World Conference on Regenerative Medicine Business Wire (Tue, Oct 20)
| | Wed, Oct 14, 2009 | | | Pluristem Therapeutics Will Present at the New England-Israel Life Sciences Summit Business Wire (Wed, Oct 14)
| | Fri, Oct 9, 2009 | | | Another Coin-Flip Bet on a Stem Cell Drug Indie Research (Fri, Oct 9)
| | Tue, Oct 6, 2009 | | | PLURISTEM THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and E EDGAR Online (Tue, Oct 6)
| | | Pluristem Therapeutics to Raise $3.0 Million in Registered Direct Offering Business Wire (Tue, Oct 6)
| | Thu, Oct 1, 2009 | | | Pluristem Provides Disclosure Pursuant to NASDAQ Marketplace Rule 5250(b)(2) GlobeNewswire (Thu, Oct 1)
| | Wed, Sep 30, 2009 | | | Stem Cell Summit Can't Excite Investors Indie Research (Wed, Sep 30)
| | Tue, Sep 29, 2009 | | | Pluristem Therapeutics Has Been Selected to Present at The Israeli Presidential Conference 2009: Facing Tomorrow, Based on the Company's Proprietary Technology and the Potential to Shape The Future of the Stem Cell Industry Business Wire (Tue, Sep 29)
| | Wed, Sep 23, 2009 | | | PLURISTEM THERAPEUTICS INC Files SEC form 10-K, Annual Report EDGAR Online (Wed, Sep 23)
| | Tue, Jul 7, 2009 | | | PLURISTEM THERAPEUTICS INC Files SEC form 8-K, Other Events EDGAR Online (Tue, Jul 7)
| | Mon, May 11, 2009 | | | PLURISTEM THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report EDGAR Online (Mon, May 11)
| | Wed, May 6, 2009 | | | PLURISTEM THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and E EDGAR Online (Wed, May 6)
| | Mon, Mar 2, 2009 | | | Small-Cap Winners and Losers: ICTG at TheStreet.com (Mon, Mar 2)
| Add PSTI News to My Yahoo!:

| |
|